Using computational approaches to repurpose a safe clinical compound

• Unité de recherche: INNOSUISSE
• Numéro de projet: 45672.1 IP-LS
• Titre du projet anglais: Using computational approaches to repurpose a safe clinical compound

Description succincte (Allemand)

Using computational approaches to repurpose a safe clinical compound

Description succincte (Anglais)

Using computational approaches to repurpose a safe clinical compound

Résumé des résultats (Abstract) (Allemand)

This project will leverage molecular modelling and artificial intelligence approaches developed by the Swiss Institute of Bioinformatics to identify new therapeutic indications for a promising bioactive, safe and well-tolerated compound, owned by the Addex Therapeutics company.